Cancer is often discovered only after it has already progressed.
That is why detection at the earliest possible stage plays a critical role in expanding treatment options and improving survival rates.
At IMC, we support international patients by providing access to advanced Japanese medical screening programs, including PET-CT examinations and genetic testing.
Regular cancer screenings are essential for early detection and disease prevention.
IMC’s screening programs go beyond standard examinations, providing comprehensive services that include individualized risk assessments and personalized treatment recommendations.
For international patients, we offer end-to-end support, covering medical interpretation, appointment coordination, and detailed reporting of results.
At IMC, we believe that finding disease early is key to protecting lives.
By combining advanced technologies such as PET-CT and genetic testing with personalized, patient-centered support, we have earned the trust of many international patients seeking care from abroad.
